NEUP Neuphoria Therapeutics Inc.

Nasdaq www.neuphoriatx.com


$ 4.61 $ 0.16 (3.6 %)    

Thursday, 30-Oct-2025 12:45:12 EDT
QQQ $ 630.61 $ -1.40 (-0.22 %)
DIA $ 477.97 $ 3.80 (0.8 %)
SPY $ 684.19 $ 0.31 (0.05 %)
TLT $ 90.68 $ 0.28 (0.31 %)
GLD $ 368.04 $ 2.90 (0.79 %)
$ 4.58
$ 4.45
$ 4.55 x 100
$ 4.64 x 2
$ 4.39 - $ 4.68
$ 2.90 - $ 21.40
549,148
na
10.8M
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-29-2025 06-30-2025 10-K
2 05-20-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 11-14-2024 09-30-2024 10-Q
5 09-30-2024 06-30-2024 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Neuphoria Therapeutics Inc. ("Neuphoria" or the "Company") (NASDAQ:NEUP), a clinical-stage biotechnology compan...

Core News & Articles

AFFIRM-1 trial did not meet primary endpoint or secondary endpointsCompany to conduct strategic review of portfolio and busines...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION